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Disorders of the locomotive system, especially those occurring due to de-
generative changes of the joints, are serious problems in daily veterinary medical 
practice. Steroid injections are the main way of treating these disorders. However, 
this approach brings usually only temporary effects of pain relief, and may cause 
many side effects. Alternative therapies focus on regeneration of damaged tissue 
using adult mesenchymal stem cells (MSCs). Since 2002, the great plasticity and 
immunomodulatory properties of MSCs isolated from adipose tissue (AdMSCs) 
have been used successfully in the treatment of degenerative joint diseases (DJD) 
of both dogs and horses. Possible simultaneous application of steroid therapy and 
stem cell transplantation could improve the commonly used clinical procedure. In 
this paper, the influence of the two steroid drugs (betamethasone and methylpred-
nisolone) on AdMSCs was evaluated on the basis of morphology and proliferation 
rate. Both steroids positively influenced the viability and proliferation state of 
cells in a concentration of 0.01 mg/ml and 0.1 mg/ml, respectively. However, the 
concentration of 1 mg/ml had a cytotoxic effect. Moreover, the lower dosage of 
steroid drugs used in the experiment did not affect the morphology of cells and 
significantly increased cellular activity. In conclusion, our data demonstrate the 
stimulating effect of steroid drugs on cell morphology, proliferation rate and cy-
tophysiological activity. These findings may influence the use of stem cells and 
steroids in applied regenerative veterinary medical practice in the future. 
Key words: Adipose-derived mesenchymal stem cells (AdMSCs), canine, 
equine, cell therapies, corticosteroids 
In the veterinary practice, locomotive system disorders affecting dogs and 
horses are the most commonly occurring therapeutic problem. The major risk 
factors of these diseases include sports-related and traumatic injuries, but these 
conditions are also enhanced by aging and/or genetic factors. The number of 
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animals suffering from degenerative joint diseases (DJDs) steadily increases 
from year to year. The National Animal Health Monitoring Systems Programme 
declared that more than 20% of all dogs have been diagnosed with osteoarthritis 
(OA) in the United States alone. Moreover, approximately 60% of equine lame-
ness cases are related to osteoarthritis (Caron and Genovese, 2003; Black et al., 
2007; Egenvall et al., 2010). Degenerative joint disorders impair animal welfare 
and thus require long-term veterinary care. These disorders not only restrict ani-
mals in their physiological activities, but in severe cases may lead to euthanasia 
(Butt, 2002; Black et al., 2008). 
Degeneration and erosion of articular cartilage are triggered by inflamma-
tion factors such as cytokines, free radicals, metalloproteinases or prostaglandins. 
The predominance of catabolic processes over anabolic ones leads to the loss of 
tissue homeostasis. The prolonged activity of inflammatory mediators results in 
cartilage disintegration and causes joint degeneration manifesting itself in 
chronic lameness (Carter et al., 1999; De Grauw et al., 2009). 
To reduce the trauma arising from articular cartilage degeneration, the 
routine veterinary treatment usually involves the application of steroid drugs. 
They are commonly used in pain management because of their anti-inflammatory 
properties. The general effect of steroids involves the inhibition of actions of 
pivotal proinflammatory cytokines, enzymes, receptors and adhesion molecules 
(Barnes, 1998; Goodrich and Nixon, 2006; Holloway et al., 2012). The most 
widely used steroids are synthetic glucocorticoids, mainly methylprednisolone 
(depo-medrol) and betamethasone. Their use, along with that of nonsteroidal 
anti-inflammatory drugs (NSAIDs), is still the primary therapy of choice (San-
derson et al., 2009; McIlwraith, 2010). However, it is well known that prolonged 
steroid treatment leads to many dangerous side effects, such as the well-known 
Cushing’s syndrome, muscle wasting, hyperglycaemia, gastropathy, hepatopa-
thy, immunosuppression, polydypsia, polyuria or water retention (Llewellyn, 
2002). However, there are some reports suggesting positive effects of steroid 
therapy, e.g. increased testosterone level in cover stallions or an elevated number 
of red blood cells. In locomotive system disorders, the influence of steroids is 
limited to pain reduction and delay of disease progress. Therefore, the patients’ 
condition improves only seemingly and usually temporarily. Sufficient and effec-
tive therapies should focus not only on the clinical signs but, most of all, on the 
regeneration of damaged tissue to restore its proper physiological functions. It 
has to be stressed that the objective of regenerative medicine is to alter the de-
velopment of disease, parallel with pain reduction. This approach is found to be 
the main goal in regenerative medicine for small and large animals (Black et al., 
2007; Hodgkiss-Geere et al., 2012). 
Auto-transplantation of stem cells is regarded as cutting edge in pain man-
agement. The last decade brought novel strategies for DJD and OA treatment us-
ing stem cell injections. Many research groups have shown that transplantations 
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of adult stem cells bring positive clinical outcomes. New populations of adult 
stem cells are still being discovered. However, it seems that adipose-derived stem 
cells (AdMSCs), together with those of bone marrow origin, play a primary role 
in veterinary clinical treatment, both in small and large animals (Gattegno-Ho et 
al., 2012; Burk et al., 2013; Hackett, 2013). In veterinary regenerative medicine, 
stem cell therapies are becoming more and more available, e.g. in the regenera-
tion of skeletal muscle and tendon injuries (Puissant et al., 2005; Del Bue et al., 
2008; Brown et al., 2012; Lin et al., 2012). The use of AdMSCs in veterinary 
practice is supported not only by their multipotent character and plasticity, but 
also by their immunomodulatory properties, manifested in the reduction of in-
flammatory processes. It was already proven that applications of AdMSCs sig-
nificantly decrease the concentration of proinflammatory cytokines at the wound 
site, which is reflected in pain and trauma relief (Gonzalez et al., 2009). 
The regenerative potential of mesenchymal stem cells can be assessed by 
several, particular parameters, including the evaluation of morphology and ultra-
structure; it is, however, often neglected by many researchers. Analysis of these 
parameters, in terms of cell transplantations, provides the selection of cells with 
the highest proliferative potential, which reflects on the regenerative capability of 
the transplant at further stages of therapy (Dimitrieva et al., 2012; Vishnubalaji et 
al., 2012). The size and localisation of nuclei, as well as cellular composition, are 
the basic parameters for determining cell condition. Another important issue is 
the analysis of the cellular physiological activity of MSCs. This feature can be 
determined by the evaluation of the localisation, size and density of microvesi-
cles (MVs). As it was reported previously, MVs shed by adult stem cells are rich in 
a broad range of growth factors and cytokines, e.g. Vascular Endothelial Growth 
Factor (VEGF), Fibroblast Growth Factor (FGF), Monocyte Chemoattractant 
Protein-1 (MCF-1), Hepatocyte Growth Factor (HGF), Insulin-like Growth Fac-
tor 1 (IGF-1) and Bone Morphogenetic Proteins (BMP), which exert effects on 
cells in their vicinity (Lai et al., 2011). Moreover, the presence of structures such 
as cytonemes and tunneling nanotubes also indicates improved cell activity and 
may correlate with the natural proliferation activity of MSCs (Yasuda et al., 
2011; Lou et al., 2012). 
The goal of this research was to analyse the influence of commonly used 
steroid drugs, namely methylprednisolone and betamethasone, on equine and ca-
nine AdMSC under culture conditions. The morphology and the viability of the 
selected cells were determined. Moreover, based on the amount and localisation 
of microvesicles, the cytophysiological activity of cultured cells was studied. 
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Materials and methods 
Isolation of AdMSCs 
Mesenchymal stem cells were isolated from subcutaneous fat tissue from 
dogs and horses. This work did not need the approval of the Local Bioethics 
Committee, as the work on animal cells and tissues is not considered an experi-
ment on animals. All stages of the procedure were performed as previously de-
scribed (Grzesiak et al., 2011a,b). Briefly, fat tissue biopsies were washed in 
Hank’s Balanced Salt Solution (HBSS, Sigma) to remove blood contaminations, 
and then minced and digested in type I collagenase (5 mg/ml). To ensure effec-
tive digestion of the tissue samples, fragments were transferred to a CO2 incuba-
tor at 37 °C for 40 min. Subsequently, samples were centrifuged at 1200 × g for 
10 min. After centrifugation, the supernatant with floating adipocytes was dis-
carded and the cell pellet with stromal vascular fraction (SVF) was suspended in 
culture media and plated into culture dishes. After 24 h, the medium was changed 
to remove non-adherent cells. Ham’s F12 medium was used for primary culture 
and DMEM with 4500 mg/L of glucose for secondary culture. The media were 
supplemented with 10% of fetal bovine serum (FBS) and with 1% of antibiotic/ 
antimycotic solution (all from Sigma). For normal growth, cultures were kept in 
incubator (5% CO2, 95% humidity, at 37 °C) and the medium was changed every 
two days on average. The cells were passaged at the same time, before running 
the tests with steroids. 
Steroids 
Methylprednisolone (depo-medrol, Pfizer) and betamethasone (Schering-
Plough) were tested in vitro at concentrations of 0.01 mg/ml, 0.1 mg/ml and 
1.0 mg/ml. 
In vitro evaluation of the effect of steroids on AdMSCs  
Cells were seeded into 24-well plates at a density of 20,000 per well. 
Stimulation with the drugs started after 6 h, i.e. when cell adhesion and spreading 
into the plate surface were noticed. Untreated cells provided a reference point for 
comparing the samples tested. All specimens were prepared in duplicates. The 
medium was changed 48 h after the cells’ propagation. Morphology and viability 
of the cells were evaluated after 24, 72 and 120 h, with regard to the results re-
ported by Nuzzi et al. (2012). 
Cytotoxicity test 
The degree of cytotoxicity induced by the drugs was assessed by evalua-
tion of metabolic activity of living cells using the resazurin–resorufin system 
(Alamar Blue, Sigma). Dye solution was added in an amount equal to 10% of the 
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culture medium volume. Cells were incubated with the dye for 2 h in a CO2 in-
cubator. After this time, supernatants were collected and measured spectropho-
tometrically by monitoring the decrease in absorbance at a wavelength of 600 nm 
with a reference wavelength of 690 nm, by means of a microplate reader (Spec-
trostar Nano, BMG Labtech). Each test included a blank containing complete 
medium without cells. To evaluate the proliferation rate, a standard curve of a 
different range of cell concentrations (2 × 104, 4 × 104, 8 × 104 and 16 × 104) with 
an absorbance directly proportional to the cell number, was constructed. 
Evaluation of cell morphology and activity 
The morphology of cells was evaluated both in the culture with drugs and 
in the control culture with untreated cells. Cell morphology was evaluated under 
inverted phase contrast microscope, epifluorescent microscope (Zeiss, Axio Ob-
server A.1) and using scanning electron microscopy (SEM, Zeiss Evo LS 15). 
For the analysis of cellular composition, diamidino-2-phenylindole (DAPI) 
was used for the staining of nuclei and phalloidin for the visualisation of actin 
filaments. Prior to staining, the cells were fixed with 4% ice-cold paraformalde-
hyde for 15 min at room temperature. After fixation, cells were washed and per-
meabilised with 0.1% Triton X-100 for 15 min at room temperature. Cells were 
washed again, stained with atto-488-labelled phalloidin for 30 min and counter-
stained with DAPI for 5 min. After staining, samples were washed three times 
and observed in an inverted, epifluorescence microscope. 
For scanning electron microscopy, the cells were fixed in 2.5% glutaralde-
hyde (1:1 in DMEM) for 30 min at room temperature, then washed three times 
with phosphate-buffered saline (PBS) and dehydrated in an ascending ethanol se-
ries (grades of 10% from 50% to 100%). Cells were observed with an SE1 detec-




Betamethasone showed slight or no toxic effect on canine and equine 
AdMSCs on the first and second days of the test. Nevertheless, after five days of 
canine AdMSC culture, the proliferation rates were approximately 50% lower than 
those obtained on the second day. However, on the fifth day of the experiment, 
different observations were made for equine AdMSC culture, where the addition 
of betamethasone in a concentration of 0.01 and 0.1 mg/ml, respectively, en-
hanced the cells’ proliferation or maintained it on the same level as in the control 
culture. Inhibition of proliferation was observed on the fifth day in cultures 
where the highest betamethasone concentration was applied (Figs 1 and 3). 
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0.01 mg/ml 0.91 1.48 0.76
0.1 mg/ml 1.64 1.12 0.64
1 mg/ml 1.47 0.91 0.11
control 1 1 1
24 hrs 48 hrs 120 hrs
 


















0.01 mg/ml 0.88 1.20 1.48
0.1 mg/ml 1.24 1.16 0.45
1 mg/ml 0.91 0.84 0.14
control 1 1 1
24 hrs 48 hrs 120 hrs
 
Fig. 2. Proliferation rates of canine AdMSC in the presence of methylprednisolone (depo-medrol) 
at different concentrations 
 
Methylprednisolone, when applied at the lowest concentration (0.01 mg/ml), 
exerted a stimulating effect on canine and equine AdMSCs during the entire 
course of culture. Addition of methylprednisolone in 0.1 mg/ml concentration 
maintained or enhanced the proliferative activity of cells only after 24 and 48 h 
of propagation, whereas the proliferation of AdMSCs was significantly lowered 
after 120 h. The highest concentration of methylprednisolone had strong cyto-
toxic effect on AdMSCs, which was particularly visible on the last day of meas-
urement (Figs 2 and 4). 
It is worth noting that the cultures of equine AdMSCs, treated with differ-
ent concentrations of the steroids tested, were re-established at the second day of 
Control 
Control 
 Co t l 
 C ol 
24 h 48 h 120 h 
24 h 48 h 120 h 
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propagation. This was manifested in higher proliferation rates obtained after 48 h 
in comparison to those obtained after 24 h (Figs 2 and 4). Regarding the culture 
of canine AdMSCs, this phenomenon was observed only when a steroid concen-


















0.01 mg/ml 0.78 1.09 1.63
0.1 mg/ml 0.84 1.09 1.08
1 mg/ml 0.62 1.01 0.25
control 1 1 1
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0.01 mg/ml 0.70 1.03 1.36
0.1 mg/ml 0.96 1.05 0.58
1 mg/ml 0.39 0.77 0.00
control 1 1 1
24 hrs 48 hrs 120 hrs
 
Fig. 4. Proliferation rates of canine AdMSC in the presence of methylprednisolone (depo-medrol) 
at different concentrations 
Morphology and cell activity of canine and equine AdMSCs 
Neither of the two drugs, when used at concentrations of 0.01 and 0.1 mg/ml, 
affected the morphology of cells during the entire course of culture. This situa-
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AdMSCs with methylprednisolone. In this case, after five-day propagation, both 
concentrations of drugs caused abnormal culture growth pattern and the forma-
tion of apoptotic bodies (Figs 5–8). 
 
Fig. 5. Morphological analysis of canine AdMSC culture in the presence and absence of  
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Fig. 6. Morphological analysis of canine AdMSC culture in the presence and absence of  
methylprednisolone (depo-medrol). Scale bar = 125 μm 
 
The highest dosage of drugs used in the research (1 mg/ml) induced mor-
phological changes in the cells and promoted the development of apoptotic bodies. 
In cultures of canine AdMSCs, the highest dosage of betamethasone caused cell 
death on the fifth day of propagation, while methylprednisolone already on the 
second day (Figs 5 and 6). Regarding the equine cultures, the presence of 1 mg/ml 
Control
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betamethasone did not induce death of the whole cell population but only signifi-
cantly reduced the number of cells on the fifth day of experiment. Methylpredni-
solone exerted a toxic effect on equine AdMSCs, which was particularly evident 
after 5 days of culture (Figs 7 and 8). 
 
Fig. 7. Morphological analysis of equine AdMSC culture in the presence and absence of  
betamethasone. Scale bar = 125 μm 
 
Control 
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Fig. 8. Morphological analysis of equine AdMSC culture in the presence and absence of  
methylprednisolone (depo-medrol). Scale bar = 125 μm 
 
The evaluation of cell activity expressed by the synthesis of microvesicles 
showed that the lowest concentration (0.01 mg/ml) of both drugs stimulated ca-
nine and equine AdMSCs. This effect was maintained throughout the entire 
course of culture (Figs 9–10). The increased presence of MVs was observed in 
all cases, always after 24 h of cell culture. However, the addition of methylpred-
Control
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nisolone and betamethasone in the highest concentration was accompanied by 
changes in cytoplasm organisation, manifested in the formation of a foamy struc-
ture. 
 
Fig. 9. Microvesicles shed from canine AdMSCs at different concentrations of betamethasone and 
methylprednisolone (depo-medrol). Scale bar = 2 μm 
Control 
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Fig. 10. Microvesicles shed from equine AdMSCs at different concentrations of betamethasone 
and methylprednisolone (depo-medrol). Scale bar = 2 μm 
 
Control 
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Discussion 
The incidence of locomotive system disorders is increasing rapidly in both 
small and large animals. Degenerative joint disorders cause lameness, reduce the 
range of motion and contribute to the patients’ suffering. The gold standard in 
DJD treatment is steroid therapy, which reduces the pain level but only in the 
short term and usually without significantly changing the long-term clinical pic-
ture. Therapeutic procedures using steroid injections are commonly available and 
applicable; however, all groups of clinicians have observed side effects as a re-
sult of prolonged steroid usage. Despite the fact that steroid therapies are associ-
ated with adverse reactions, they have been the main treatment modality for DJD 
for over thirty years (Supance, 1983; Carter et al., 1999).  
The discovery of adult stem cells has offered an alternative therapeutic 
approach (Black et al., 2007). As was reported by Zuk et al. (2002), stem cells 
can be easily obtained from adult tissues and differentiated in vitro into various 
lineages. Successful outcomes were noticed after injections of adult mesenchy-
mal stem cells of different origin. Regeneration of degenerative tissue using stem 
cells injections is still a novel advance in modern veterinary practice. This ap-
proach focuses on restoring the physiological function of tissues, simultaneously 
with pain relief. The process of tissue regeneration is complex, and still has to be 
investigated in detail (Hackett, 2013). An important observation is that AdMSCs 
possess immunomodulatory properties, especially the ability to secrete anti-
inflammatory factors. Therefore, as tissue heals, pain relief is also prominent. 
Moreover, pain reduction that results from the action of injected cells occurs after a 
certain period of time, but not immediately. In contrast, the application of steroids 
provides significant and immediate pain reduction, but this effect wanes after a 
relatively short time, two to three weeks (Coleman et al., 2010; Qui et al., 2012). 
We assumed that the combination of stem cells and steroid drugs in spe-
cific proportions may not only provide an immediate pain-relieving effect but 
could also lead to an efficient regeneration of damaged tissue. Our results sug-
gest that steroids affect the viability and proliferation rate of cells in both canine 
and equine cell cultures. We observed that at concentrations of 0.01 mg/ml and 
0.1 mg/ml both steroid drugs exerted a stimulating effect on the proliferation and 
viability of both equine and canine AdMSCs and, moreover, they did not affect 
the morphology of cells. The stimulated stem cells showed proper, fibroblastic 
shape with big and eccentrically located nuclei. 
While the lowest concentrations had a favourable influence on cell cul-
tures, stimulating them to higher proliferation, the concentration of 1 mg/ml had 
a cytotoxic effect, which was particularly evident on the fifth day of culture, 
when a rapid decrease of proliferation rate and cell death were noticed. These 
findings correlate with the results of Nuzzi et al. (2012); however the experimen-
tal model of the latter research group was based on the use of human bone mar-
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row mesenchymal stem cells (hBMSC). Therefore, it seems that a diverse popu-
lation of MSCs isolated from different species reacts similarly to the same group 
and concentration of steroid drugs. Comparing the effects of the two steroids 
studied in this experiment, betamethasone was less toxic to equine cells and 
methylprednisolone to canine cells. 
On the basis of the results obtained, we presume that the physical proper-
ties of steroid drugs should also be taken into consideration. The drug particles 
present in the cultures could have been an obstacle to cellular adhesion, move-
ment and proliferation, and consequently it could have been partially responsible 
for the observed negative effects of the drugs. Our results demonstrated that ster-
oids promote the proliferation of AdMSCs. In cases where cells were stimulated 
with drug concentrations of 0.01 and 0.1 mg/ml, we observed not only higher 
proliferation rate but also intensified activity of the cells. This was manifested in 
the number of produced MVs and the formation of specific cellular structures, 
namely cytonemes and tunneling nanotubes. Based on common knowledge, we 
assume that the presence of microvesicles at the wound site could reflect the pro-
regenerative potential of stem cells. As it was demonstrated, MVs rich in numer-
ous bioactive factors play a crucial role in cell paracrine and autocrine signalling 
(Ratajczak et al., 2006a, b). 
On the basis of the results obtained, in order to reduce the pain and to im-
prove the regeneration of tissue damaged due to DJD, it seems to be reasonable 
to combine stem cell therapy and steroid drugs in particular proportions. Finally, 
for the further clinical application of this therapeutic approach, in vivo studies are 
crucial to better understand the complexity of regeneration mechanisms. We pre-
sume that in-depth analysis of the impact of steroid drugs on the biology of MSCs 
will open up new areas of eventual therapeutic strategies. If these conclusions are 
confirmed by clinical trials, this will result in the elaboration of improved stem cell 
therapies for DJD. 
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